Re-irradiation for children with recurrent medulloblastoma in Toronto, Canada: a 20-year experience
- 29 August 2019
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 145 (1) , 107-114
Abstract
Children with recurrent medulloblastoma have a poor prognosis. Re-irradiation is an option for some patients, but has not been well-studied in the era of molecular characterization for pediatric medulloblastoma.Keywords
This publication has 21 references indexed in Scilit:
- Re-irradiation of locally recurrent pediatric intracranial ependymoma: Experience of the French society of children’s cancerRadiotherapy and Oncology, 2019
- Reirradiation for Recurrent Pediatric Central Nervous System Malignancies: A Multi-institutional ReviewInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2017
- Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort studyThe Lancet Oncology, 2017
- Intertumoral Heterogeneity within Medulloblastoma SubgroupsCancer Cell, 2017
- Reirradiation of Pediatric Tumors Using Hypofractionated Stereotactic RadiotherapyTechnology in Cancer Research & Treatment, 2016
- RBApp: Creation and Patterns of Use of an Educational Mobile Application for Radiobiology Calculations in Radiation TherapyJournal of Medical Imaging and Radiation Sciences, 2015
- Reirradiation of recurrent medulloblastoma: Does clinical benefit outweigh risk for toxicity?Cancer, 2014
- Reirradiation of relapsed brain tumors in childrenReports of Practical Oncology and Radiotherapy, 2012
- Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNETPediatric Blood & Cancer, 2008
- Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trialThe Lancet Oncology, 2006